Synonyms: DS-1594a | DS-1594b
Compound class:
Synthetic organic
Comment: Emilumenib (DS-1594) is an orally available small-molecule menin inhibitor [1]. It binds to the nuclear protein menin (MEN1) and prevents its interaction with menin-mixed lineage leukemia (MLL; KMT2A, lysine methyltransferase 2A), as a mechanism to disrupt proleukemogenic signalling via the menin-KMT2A complex in acute leukemias with KMT2A rearrangements.
|
|
References |
1. Numata M, Haginoya N, Shiroishi M, Hirata T, Sato-Otsubo A, Yoshikawa K, Takata Y, Nagase R, Kashimoto Y, Suzuki M et al.. (2023)
A novel Menin-MLL1 inhibitor, DS-1594a, prevents the progression of acute leukemia with rearranged MLL1 or mutated NPM1. Cancer Cell Int, 23 (1): 36. [PMID:36841758] |